Bangkok Dusit Medical Services PCL (BKK:BDMS) Other Stockholders Equity: ฿14,206 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:BDMS Bangkok Dusit Medical Services PCL BKK:BDMS
90 GF Score
Price ฿19.60
GF Value ฿28.10
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bangkok Dusit Medical Services PCL Other Stockholders Equity?

Bangkok Dusit Medical Services PCL BKK:BDMS +1.03% 90 Other Stockholders Equity is ฿14,206 Mil as of Mar. 2026. GuruFocus rates BKK:BDMS with a GF Score™ of 90/100 and a GF Value™ of ฿28.10 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Bangkok Dusit Medical Services PCL's Other Stockholders Equity for the quarter that ended in Mar. 2026 was ฿14,206 Mil.

Bangkok Dusit Medical Services PCL's quarterly Other Stockholders Equity increased from Sep. 2025 (฿11,742 Mil) to Dec. 2025 (฿13,966 Mil) and increased from Dec. 2025 (฿13,966 Mil) to Mar. 2026 (฿14,206 Mil).

Bangkok Dusit Medical Services PCL's annual Other Stockholders Equity increased from Dec. 2023 (฿11,512 Mil) to Dec. 2024 (฿11,803 Mil) and increased from Dec. 2024 (฿11,803 Mil) to Dec. 2025 (฿13,966 Mil).

Bangkok Dusit Medical Services PCL Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Bangkok Dusit Medical Services PCL's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bangkok Dusit Medical Services PCL Other Stockholders Equity Chart

Bangkok Dusit Medical Services PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,141.21 10,173.97 11,511.87 11,802.56 13,966.03

Bangkok Dusit Medical Services PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,006.23 11,835.19 11,741.95 13,966.03 14,205.80
BKK:BDMS
90GF Score
Bangkok Dusit Medical Services PCL BKK:BDMS
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bangkok Dusit Medical Services PCL Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ฿14,206 Mil mean?
Bangkok Dusit Medical Services PCL (BKK:BDMS) has a Other Stockholders Equity of ฿14,206 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Bangkok Dusit Medical Services PCL and its competitors.
Is Bangkok Dusit Medical Services PCL's Other Stockholders Equity too high?
Bangkok Dusit Medical Services PCL's current Other Stockholders Equity is ฿14,206 Mil. Overall, Bangkok Dusit Medical Services PCL has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bangkok Dusit Medical Services PCL's Other Stockholders Equity compare to HCA and THC?
Bangkok Dusit Medical Services PCL's Other Stockholders Equity of ฿14,206 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Providers & Services company?
A good Other Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Bangkok Dusit Medical Services PCL and its competitors. Bangkok Dusit Medical Services PCL's current Other Stockholders Equity is ฿14,206 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Dusit Medical Services PCL stock overvalued right now?
Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL (BKK:BDMS) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿28.10, compared to a current price of ฿19.60 — trading 30.2% below its estimated fair value. The current Other Stockholders Equity is ฿14,206 Mil. Bangkok Dusit Medical Services PCL's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Bangkok Dusit Medical Services PCL (BKK:BDMS), the current Other Stockholders Equity is ฿14,206 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bangkok Dusit Medical Services PCL (BKK:BDMS) Overvalued in 2026?

Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL stock appears to be undervalued. The current stock price of ฿19.60 is trading 30.2% below its estimated GF Value™ of ฿28.10. GuruFocus considers Bangkok Dusit Medical Services PCL to be Significantly Undervalued.

Key valuation signals for BKK:BDMS:

  • Other Stockholders Equity: ฿14,206 Mil
  • GF Value™: ฿28.10 vs. price of ฿19.60 (30.2% below fair value)
  • GF Score™: 90/100 with 2 warning signs

No single metric tells the full story. See the BKK:BDMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bangkok Dusit Medical Services PCL Business Description

Address New Petchburi Road, 2, Soi Soonvijai 7, Bang Kapi, Huaykwang, Bangkok, THA, 10310
Bangkok Dusit Medical Services PCL operates a network of private hospitals in Thailand and some overseas markets, under the Bangkok Hospital, Phyathai Hospital, Samitivej Hospital, Paolo Hospital, BNH Hospital, and Royal International Hospital brands. The company has two business segments, namely hospital operations and other businesses that support hospital business, such as medical laboratories, production and distribution of pharmaceutical products/medical equipment/saline, pharmacies, asset management for healthcare business, accounting services, technology and information services, training business, and insurance broker. The company's hospital operations generate the vast majority of its revenue.
90GF Score

Get the complete analysis for BKK:BDMS

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿19.60
Price
฿28.10
GF Value